Table 2 Clinical features of lung adenocarcinoma cases as revealed by immunohistochemical staining

From: Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy

Characteristic

(%)

Age (year)

 Median

64.8

 Range

45–82

Gender

 Male

54 cases (60.0%)

 Female

36 cases (40.0%)

Pathological stage

 IA

33 cases (36.7%)

 IB

57 cases (63.3%)

Existence of recurrence

 (+)

41 cases (45.6%)

 (−)

49 cases (54.4%)

PAC with urasil-tegafur

 (+)

51 cases (56.7%)

 (−)

39 cases (43.3%)

  1. PAC=postoperative adjuvant chemotherapy.
Back to article page